IDX — Integral Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$911.93m
- AU$1.45bn
- AU$627.97m
- 71
- 45
- 70
- 68
Annual cashflow statement for Integral Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | C2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -2.13 | -5.42 | -3.66 | -1.24 | -19.5 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 69.6 | 37.1 | 67.1 | 66.2 | 73.8 |
| Capital Expenditures | -20.3 | -27.8 | -44 | -23.9 | -59.8 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -36.4 | -27.9 | -85 | -4.03 | -5.23 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -56.7 | -55.7 | -129 | -27.9 | -65 |
| Financing Cash Flow Items | -0.139 | -2.88 | — | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -7.83 | 81.1 | -27.6 | -29.5 | 0.71 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.24 | 61 | -89.3 | 8.58 | 9.67 |